The universal effects of low-dose interleukin-2 across 13 autoimmune diseases in a basket clinical trial.
Lorenzon R, Ribet C, Pitoiset F, Aractingi S, Banneville B, Beaugerie L, Berenbaum F, Cacoub P, Champey J, Chazouilleres O, Corpechot C, Fautrel B, Mekinian A, Regnier E, Saadoun D, Salem JE, Sellam J, Seksik P, Vicaut E, Rosenzwajg M, Klatzmann D.
Lorenzon R, et al. Among authors: berenbaum f.
J Autoimmun. 2024 Apr;144:103172. doi: 10.1016/j.jaut.2024.103172. Epub 2024 Feb 7.
J Autoimmun. 2024.
PMID: 38330545